Meaningful relief with flurbiprofen 8.75 mg spray in patients with sore throat due to upper respiratory tract infection

Sore throat is mainly caused by the upper respiratory tract infection (URTI). The number of studies recommended flurbiprofen for the treatment of URTI. But there was variability in the results of these studies. Therefore, in this study, it was showed that 8.75mg of flurbiprofen provides rapid, long-lasting and clinically meaningful relief from sore throat.

Assess the effectiveness of 8.75 mg Flurbiprofen sprays for a sore throat.

The adults with the sore throat due to upper respiratory tract infections administrated with Flurbiprofen or placebo spray and used Sore Throat Relief Rating Scale to assess the pain relief among the patients.

Significant pain relief was seen from 20min to 6h among the patients treated with Flurbiprofen spray than placebo. The Sore Throat Scale exhibited a ≥-2.2 reduction in sore throat severity from 75min to 6h, presenting a significant relief. Considerably more patients from flurbiprofen spray group reported ≥30min of ‘at least moderate’ relief than placebo over 6h. The adverse events noticed during the analysis were mild.

Flurbiprofen spray delivers a rapid, long-lasting and clinically significant relief from a sore throat.